Expertise in
36
conditions

Jing Y. Peng

No.160 Pujian Road, 
Shanghai, CN 
Expertise in
36
conditions
No.160 Pujian Road, 
Shanghai, CN 

Overview

Jing Peng practices practicing medicine in Shanghai, China.

Ms. Peng is highly rated in 36 conditions, according to our data. Her clinical expertise encompasses Epilepsy, Epilepsy in Children, West Syndrome, Cordotomy, and Hysterectomy.

She is actively involved in clinical research, co-authoring 814 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

No.160 Pujian Road, Shanghai, 200127, China
Other Locations
Hainan Branch, Sanya, China
87 Xiangya Road, Changsha, China
87 Xiangya Road, Changsha, 410008, China
No. 519 Kunzhou Road, Kunming, 650118, China
3 Taicheng Road, Yangling, 712100, China
320 XunYang East Road, Jiujiang, 332000, China
264 MinDe Road, Nanchang, 330006, China
No. 1630 Dongfang Road, Dongfang, 200127, China
Luoshi Road 122, Wuhan, China
196 West Huayang Road, Yangzhou, China
No.24 Block 1, Xuefu Road, Chengdu, 610225, China
Fuxing 28# Road, Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Enrollment Status: Completed
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
Enrollment Status: Terminated
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
View 2 Less Clinical Trials

814 Total Publications

Construction of a genotype-phenotype database and machine learning models for pseudohypertrophic muscular dystrophy
Construction of a genotype-phenotype database and machine learning models for pseudohypertrophic muscular dystrophy
Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: August 17, 2026

Frequently Asked Questions about Jing Y. Peng

Is Jing Y. Peng a top-rated expert for Epilepsy?

MediFind is an objective health platform that identifies experts based on real-world data. Jing Y. Peng is classified as an Distinguished expert for Epilepsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jing Y. Peng participate in research or clinical trials?

Yes. Jing Y. Peng has published 814 articles and abstracts on conditions like Epilepsy. You can view a list of Jing Y. Peng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Peng's expertise for a condition
ConditionClose
    View All 31 Advanced Conditions
    View All 164 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile